Clinical Trial Update: Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating on the cardiovascular risk impact of methotrexate alone versus methotrexate with vitamin D in patients with psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Cairo University | Conditions: Psoriasis | Phase 4 | Status: UNKNOWN